Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

Genome-wide studies highlighted the effect in Crohn's disease (CD) and ulcerative colitis (UC) susceptibility of single nucleotide polymorphisms (SNPs) in 3p21, where BSN (bassoon), MST1 (macrophage stimulating-1) and MST1R (MST1 Receptor) genes map. MST1R expression was significantly downregulated in multiple sclerosis (MS) compared with control brains, resembling findings in the MS mouse model. We pursued to replicate the effect of this locus on inflammatory bowel diseases and to evaluate its contribution to MS risk. Polymorphisms rs9858542, rs2131109 and rs1128535 were analysed by TaqMan assays in Spanish patients (370 CD, 405 UC and 415 MS) and 800 ethnically matched controls. Allele frequencies of these SNPs were significantly different in CD patients compared with controls [rs9858542: P = 0.001, Odds ratio (OR) = 1.35; rs2131109: P = 0.0005, OR = 1.37; rs1128535: P = 0.007, OR = 0.78] and, specifically, in the ileal phenotype [rs9858542: P = 0.0004, OR = 1.47; rs2131109: P = 0.00009, OR = 1.52; rs1128535: P = 0.02, OR = 0.69]. No differences were detected between UC or MS patients and control individuals. The effect of this locus on CD predisposition was replicated, but no influence on UC or MS predisposition could be detected. This susceptibility locus seems to affect mainly to the ileal CD subphenotype, although this point awaits further corroboration in independent cohorts. Genes and Immunity (2009) 10, 631-635; doi:10.1038/gene.2009.56; published online 6 August 2009